Granite Investment Partners, LLC Aclaris Therapeutics, Inc. Transaction History

Granite Investment Partners, LLC

  • $2.26 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 08, 2018
SELL
$14.38 - $20.89 $118,347 - $171,924
-8,230 Closed
0 $0
Q2 2018

Aug 06, 2018
BUY
$16.46 - $20.33 $135,465 - $167,315
8,230 New
8,230 $164,000
Q1 2018

May 04, 2018
SELL
$17.08 - $25.64 $391,371 - $587,514
-22,914 Closed
0 $0
Q4 2017

Feb 01, 2018
BUY
$21.47 - $27.8 $491,963 - $637,009
22,914
22,914 $565,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email